MedTrace Logo

Efficacy and Safety of a New Sperm Capacitation Method

NCT06742437 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-02-27

No results posted yet for this study

Summary

Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.

Conditions

  • Reproductive Issues
  • Male Infertility
  • Asthenozoospermia
  • Oligozoospermia
  • Teratozoospermia

Interventions

DEVICE

Standard sperm preparation

Sperm samples in the control group will undergo traditional processing

DEVICE

HyperSperm

Sperm samples in the experimental group will undergo product-specific processing

Sponsors & Collaborators

  • Fecundis Lab SL

    lead OTHER

Principal Investigators

  • Mariona Rius Mas, PhD · Fertty

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-14
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06742437 on ClinicalTrials.gov